Stay updated on HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 on the page, a minor site maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Tianjin Municipality as a new study location and updated the location section. The old 'Tianjin Municipality Locations' entry was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check54 days agoChange DetectedThe Publications section now notes that listed publications are auto-filled from PubMed and may not pertain to the study. The footer revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedA government funding and operating status notice at the top of the page has been removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments to the page without altering core study details. There are no additions or deletions to sections such as Study Overview, Eligibility Criteria, Interventions, or Outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check104 days agoChange DetectedAdd: government-operating-status notice and v3.2.0; Remove: resource topic for Autoimmune thrombocytopenic purpura and v3.1.0.SummaryDifference5%

Stay in the know with updates to HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.